Agenus to Participate in Upcoming September 2026 Investor Conferences
LEXINGTON, Mass.--(BUSINESS WIRE)--$AGEN #BOT--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that Robin Taylor, Ph.D., Chief Commercial Officer, and Zack Armen, Head of Corporate Development and Investor Relations, will participate in fireside chats and one-on-one investor meetings at two upcoming investor conferences in September.
- Cantor Global Healthcare Conference 2026 September 9 -11, 2026; New York, NY Fireside Chat: Tuesday, September 8, 2026 | 11:30 a.m-12:00 p.m. ET
- H.C. Wainwright 28th Annual Global Investment Conference September 14-16, 2026; New York, NY Fireside Chat: Monday, September 14, 2026 | 3:00 p.m.-3:30 p.m. ET
An archived recording of the fireside chats will be available for 90 days following each event on the Events & Presentations section of the Agenus investor relations website at Agenus Inc. - Events.
About Agenus
Agenus is a leading immuno-oncology company targeting cancer with a comprehensive pipeline of immunological agents. The company was founded in 1994 with a mission to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants. Agenus has robust end-to-end development capabilities, across commercial and clinical cGMP manufacturing facilities, research and discovery, and a global clinical operations footprint. Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or @agenus_bio. Information that may be important to investors will be routinely posted on our website and social media channels.
Contacts
Investors
917-362-1370 | [email protected]
Media
781-674-4422 | [email protected]